Semaglutide for people with methamphetamine use disorder
Part of Mental health clinical trials.
This trial tests if semaglutide (a medicine used for diabetes and weight loss) can help reduce methamphetamine use. If you qualify, you might get the study drug and support to help you cut back or stop using methamphetamine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older and have a diagnosis of moderate to severe methamphetamine use disorder.
- You must have used methamphetamine at least 14 days out of the last 28 days, and have a positive saliva drug test for methamphetamine at screening.
- You must be willing to attend study visits and follow protocol, including using effective birth control during the study and for 60 days after the last dose (if you can become pregnant).
- You cannot have diabetes (or be taking diabetes drugs) and your body mass index (BMI) must be at least 22.
- You cannot have a history of pancreatitis or medullary thyroid cancer, and you must not currently be in another clinical trial or live in a residential rehab program during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether tirzepatide, a medication that may help reduce cravings and weight, can help people who use methamphetamine cut down or stop. It aims to find a new treatment option for methamphetamine use disorder.
This study tests whether a medication called 'Glutide' (a GLP-1 agonist, similar to drugs used for diabetes) can help people who want to stop or cut down on methamphetamine. It's for those with moderate to severe meth use disorder who have used meth on at least 15 of the past 30 days.
This study tests whether a once-weekly injection of semaglutide (a GLP-1 receptor agonist) can reduce opioid use in people who are already on buprenorphine or methadone but still using opioids. It lasts about 19 weeks.
This study tests whether semaglutide (a medication used for weight management) can help people on buprenorphine or methadone reduce their opioid use. If it works, it could provide additional support during recovery.
This study tests whether semaglutide, a medication used for weight management, can help reduce cocaine use in people with cocaine use disorder. You may qualify if you have a body mass index (BMI) of 25 or higher and recently used cocaine.
This study is testing whether semaglutide, a medication already used for diabetes and weight loss, can help people with HIV who also have an alcohol use disorder cut back on drinking. It is for patients treated at the Atlanta VA Healthcare System.
Hear when a new Methamphetamine Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.